InvestorsHub Logo
Followers 66
Posts 1221
Boards Moderated 0
Alias Born 04/02/2020

Re: None

Wednesday, 07/01/2020 6:31:46 PM

Wednesday, July 01, 2020 6:31:46 PM

Post# of 232336
THIS WAS THE NEWS OF THE DAY
Everyone should re-listen to today’s interview... specifically at ~7 min mark when the topic of Dr. Jonah Sacha’s HIV cure project on animals was discussed. The study results demonstrate Leronlimab can mimic genetic mutation that results in loss of CCR5 thereby making HIV cure a possibility for any HIV patient who requires bone marrow transplant. CytoDyn have already identified 2 candidates for trial! Just the thought of this possibility is mind-blowing!!!

https://www.google.com/amp/s/www.proactiveinvestors.com/companies/amp/news/923234

For those throwing rocks in a glass house at the character of NP and scoffing at his statement, you will be hard-pressed to try those tactics on Dr. Sacha... if you’re unfamiliar with Dr. Sacha, you can review the links below for some background and realize his research brings significant credibility...

https://www.ohsu.edu/people/jonah-b-sacha-phd

https://www.proactiveinvestors.com/companies/news/223507/cytodyn-taps-top-aids-research-expert-jonah-sacha-as-senior-science-advisor-223507.html

https://www.globenewswire.com/news-release/2020/01/27/1975482/0/en/CytoDyn-Abstract-by-Dr-Jonah-Sacha-for-Use-of-Leronlimab-as-PrEP-is-Accepted-by-the-Keystone-Symposia-on-HIV-Pathogenesis-and-Cure.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News